Qubis
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.
StimOxyGen
11 Mar 2025
StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy
StimOxyGen develops oxygen delivery therapies designed to improve tumour response to radiotherapy and immunotherapy by addressing hypoxia in solid cancers, initially focusing on pancreatic cancer.
Qubis
- 1(12 months)
- qubis.co.uk
- Update Information
More venture news
- 17 Mar 2026
SignalsSignals secures an £880k seed round from strategic investors to help publishers evaluate integrity of research
SeedEducation - 18 Mar 2026
VerbaFloVerbaFlo lands a £5m seed round led by Pi Labs to power global real estate communications with conversational AI
SeedProperty - 16 Mar 2026
Ternary TherapeuticsTernary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
SeedLife Sciences
